Molecular Diagnostics Company Empire Genomics Raised $1.75M in Funding

Empire Genomics, a Buffalo, NY-based molecular diagnostics company, raised $1.75m financing round.

The round was led by existing investor BroadOak Capital Partners with participation from Rand Capital Corporation (NASDAQ: RAND).

The company will use the proceeds to continue growing its business through investments in sales and marketing, automation, and increasing scale of operations as well as the launching of additional proprietary molecular diagnostics.

Led by Anthony Johnson, President and CEO, Empire Genomics offers comprehensive assay services for diagnosing and guiding patient therapeutic treatments.
It was created in 2006 from research started at Roswell Park Cancer Institute in Buffalo, NY.



Join the discussion